Published in
Elsevier, European Journal of Pharmaceutical Sciences, (123), p. 371-376
DOI: 10.1016/j.ejps.2018.08.002
Links
Tools
Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152)
Journal article published in 2018 by
Gábor Oláh,
Nikoletta Dobos,
György Vámosi 
,
Zsuzsanna Szabó,
Éva Sipos,
Klára Fodor,
Kristóf Harda,
Andrew V. Schally,
Gábor Halmos
,
Zsuzsanna Szabó,
Éva Sipos,
Klára Fodor,
Kristóf Harda,
Andrew V. Schally,
Gábor Halmos
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 